Michael Lourenco Costa Sabra Health Care Reit, Inc. (SBRA) insider trading activity

Michael Lourenco Costa is Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc.. Currently has a direct ownership of 252,850 shares of SBRA, which is worth approximately $4.78 Million. The most recent transaction as insider was on Aug 30, 2024, when has been sold 2,624 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 253K

1.05% 3M change

38.0% 12M change

Total Value Held $4.78 Million

Michael Lourenco Costa Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 30 2024	BUY Grant, award, or other acquisition	-	2,624 Added 1.03%	252,850 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	3,004 Added 1.19%	250,226 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	3,089 Added 1.23%	247,222 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	23,209 Added 8.68%	244,133 Common Stock
Jan 05 2024	SELL Payment of exercise price or tax liability	$6,383 $13.64 p/Share	468 Reduced 0.21%	220,924 Common Stock
Dec 28 2023	BUY Grant, award, or other acquisition	-	36,468 Added 14.14%	221,392 Common Stock
Nov 30 2023	BUY Grant, award, or other acquisition	-	1,706 Added 0.91%	184,924 Common Stock
Sep 01 2023	BUY Open market or private purchase	$24,590 $12.63 p/Share	1,947 Added 1.05%	183,218 Common Stock
Aug 31 2023	BUY Grant, award, or other acquisition	-	1,942 Added 1.06%	181,271 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	2,103 Added 1.16%	179,329 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$60,781 $11.8 p/Share	5,151 Reduced 2.82%	177,226 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	14,894 Added 7.55%	182,377 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	1,939 Added 1.14%	167,483 Common Stock
Jan 28 2023	SELL Payment of exercise price or tax liability	$20,620 $13.46 p/Share	1,532 Reduced 0.92%	165,544 Common Stock
Jan 28 2023	BUY Grant, award, or other acquisition	-	4,437 Added 2.59%	167,076 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$13,204 $13.1 p/Share	1,008 Reduced 0.62%	162,639 Common Stock
Dec 27 2022	BUY Grant, award, or other acquisition	-	34,777 Added 17.53%	163,647 Common Stock
Nov 30 2022	BUY Grant, award, or other acquisition	-	1,016 Added 0.78%	128,870 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	-	859 Added 0.67%	127,854 Common Stock
May 31 2022	BUY Grant, award, or other acquisition	-	897 Added 0.7%	126,995 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	916 Added 0.72%	126,098 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$17,940 $13.54 p/Share	1,325 Reduced 1.05%	125,182 Common Stock
Dec 28 2021	BUY Grant, award, or other acquisition	-	24,696 Added 16.33%	126,507 Common Stock
Nov 30 2021	BUY Grant, award, or other acquisition	-	444 Added 0.43%	101,811 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	-	353 Added 0.35%	101,367 Common Stock

MLC

Michael Lourenco Costa

Executive VP, CFO & Secretary

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBRA shares.

Notify only if

Value

Insider Trading

Get notified when an Sabra Health Care Reit, Inc. insider buys or sells SBRA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sabra Health Care REIT, Inc.

Track Activities on SBRA

Account